Biogena Group Invest Ag
BIO.VI
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.55M
Close$
Share Statistics
| Market cap | $20.55 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.05 (0.97%) |
| Earnings per Share | $0 |
| Beta | 0.78 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biogena Group Invest Ag
3 employees
CEO: Julia Ganglbauer Biogena Group Invest AG, headquartered in Salzburg, Austria, specializes in the supply of nutritional supplements.